Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

Clinical trial NCT06814145 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06814145
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2025-04-16
Primary completion: 2035-08-10
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.